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Background: OASIS is an ER stress sensor 
expressed in the large intestine. 
Results: Mature goblet cells are decreased in 
Oasis-/- mice. Knockdown of the Oasis 
transcript impairs the maturation of goblet 
cells. 
Conclusion: OASIS plays crucial roles in 
terminal differentiation of goblet cells. 
Significance: OASIS signaling during the ER 
stress response is involved in cell 
differentiation and maturation. 
 
OASIS is a bZIP transmembrane 
transcription factor localized in the 
endoplasmic reticulum (ER) that is cleaved 
in its transmembrane region in response to 
ER stress. This novel ER stress transducer 
has been demonstrated to express in 
osteoblasts and astrocytes and promote 
terminal maturation of these cells. 
Additionally, OASIS is highly expressed in 
goblet cells of the large intestine. In this 
study, we investigated the roles of OASIS in 
goblet cell differentiation in the large 
intestine. To analyze the functions of OASIS 
in goblet cells, we examined morphological 
changes and the expression of goblet cell 
differentiation markers in the large intestine 
of Oasis-/- mice. By disrupting the Oasis 
gene, the number of goblet cells and 
production of mucus were decreased in the 
large intestine. Oasis-/- goblet cells showed 
abnormal morphology of mucous vesicles 
and rough ER. The expression levels of 
mature goblet cell markers were lower, and 
conversely those of early goblet cell markers 
were higher in Oasis-/- mice, indicating that 
differentiation from early to mature goblet 
cells is impaired in Oasis-/- mice. To 
determine the association of OASIS with 
other factors involved in goblet cell 
differentiation, in vitro experiments using 
cell culture model were performed. We 
found that OASIS was activated in response 
to mild ER stress which is induced in 
differentiating goblet cells. Knockdown of 
the Oasis transcript perturbed goblet cell 
terminal differentiation. Together, our data 
indicate that OASIS plays crucial roles in 
promoting the differentiation of early goblet 
cells to mature goblet cells in the large 
intestine. 
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 The endoplasmic reticulum (ER) is a 
central cellular organelle responsible for the 
synthesis, folding and posttranslational 
modifications of proteins destined for the 
secretory pathway. A number of cellular stress 
conditions lead to the accumulation of 
unfolded or misfolded proteins in the ER 
lumen. These conditions, which are 
collectively termed ER stress, have the 
potential to induce cellular damage (1, 2). The 
ER responds to these perturbations by 
activating an integrated signal transduction 
pathway through the ER stress transducers, 
which is called the unfolded protein response 
(UPR) (3-5). The UPR involves at least three 
distinct components; 1) translational 
attenuation to decrease the demands made on 
the organelle (6); 2) transcriptional induction 
of genes encoding ER-resident chaperones to 
facilitate protein folding (7, 8); and 3) 
ER-associated degradation (ERAD) to degrade 
the unfolded proteins accumulated in the ER (9, 
10). If these strategies fail, cells undergo ER 
stress-induced apoptosis (11, 12). The UPR 
was originally described as a system by which 
cells evade damage in response to acute ER 
perturbation. However, recent advances have 
revealed that the UPR also provides important 
signals for regulating cell differentiation and 
maturation, or the maintenance of basal cellular 
homeostasis (13-16). 
  Previously, we identified OASIS (old 
astrocyte specifically induced substance) as a 
novel ER stress transducer (17). OASIS is 
basic leucine zipper (bZIP) transcription factor 
that belongs to the cyclic AMP-responsive 
element (CRE)-binding protein/activating 
transcription factor (ATF) family. Although 
OASIS is localized to the ER membrane under 
normal conditions, it is cleaved at the 
membrane in response to ER stress. 
Consequently, its cleaved N-terminal 
cytoplasmic domain, which contains the bZIP 
domain, translocates into the nucleus where it 
activates the transcription of target genes (18, 
19). High expression of OASIS was observed 
in the osteoblasts of osseous tissues and the 
astrocytes of the central nervous system 
(20-22). From the analysis of knockout mice, 
OASIS has been demonstrated to be involved 
in terminal differentiation and osteoblasts 
(23-25) and astrocytes (submitted by Saito). 
The intestinal epithelium is composed of 
four distinct cell types, including the absorptive 
enterocytes and the goblet, Paneth and 
enteroendocrine secretory cell lineages (26, 27). 
Stem cells are committed to generate these 
lineages by the Wnt and Notch signaling 
cascades: Wnt signaling is required for the 
generation of the secretory lineages, whereas 
Notch signaling is necessary for the 
differentiation of enterocytes (28, 29). 
However, the molecular mechanisms 
underlying the differentiation of intestinal 
epithelial cells are incompletely defined. 
Recently, the ETS (E26 
transformation-specific)-domain transcription 
factor, SPDEF (SAM-pointed 
domain-containing ETS-like factor) (30, 31), 
has been reported to act downstream of 
ATOH1 (32), which is an essential determinant 
of secretory lineages downstream of β-catenin 
(33, 34). Maturation of Paneth and goblet cells 
has been shown to be impaired in Spdef 
deficient mice, whereas immature secretory 
progenitors accumulate in the intestine (35). 
These observations suggest that SPDEF 
promotes the terminal differentiation of a 
secretory progenitor pool into Paneth and 
goblet cells. Interestingly, the expression of 
CREB4, an ER stress transducer that is 
structurally similar to OASIS, is completely 
abolished in Spdef-deficient Paneth and goblet 
cells (35). These observations suggest that the 
expression of CREB4 is controlled at 
downstream of SPDEF, and that ER stress 
response signaling through ER stress 
transducers such as CREB4 mediates the 
differentiation and maturation of secretory cell 
lineages in the intestinal epithelium. In this 
study, we investigated the roles of the ER 
stress transducer OASIS, which is expressed in 
the crypt base of the large intestinal epithelium, 
in the differentiation of goblet cells. 
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Consequently, we demonstrated that OASIS 
plays crucial roles in promoting the terminal 
differentiation of goblet cells in the large 
intestine. 
EXPERIMENTAL PROCEDURES 
Animals – 3-week old C57BL/6 mice or 
Oasis-/- mice were used in this study. The 
Oasis-/- mice were previously established in 
our laboratory (22-24). In all studies comparing 
wild-type and Oasis-/- mice, sex-matched 
littermates derived from the mating of Oasis+/- 
mice were used. The experimental procedures 
and housing conditions for animals were 
approved by the Committee of Animal 
Experimentation, Hiroshima University. 
 
Cell culture, treatments and transfection − 
LS174T cells were cultured in Eagle's minimal 
essential medium supplemented with 10% FCS 
and 1% non-essential amino acids. LS174T 
cells were cultured overnight in 9.2 cm2 dish 
for RNA or protein isolation, and in a Lab–Tek 
Chamber Slide (Nalge Nunc) for periodic 
acid-Schiff (PAS) staining. Subsequently, cells 
were treated with 2 mM sodium butyrate, 
which induces LS174T cells to differentiate to 
mature goblet cells. For Oasis knockdown 
experiments, LS174T cells were transfected 
with 1 μg Oasis siRNA (predesigned siRNA 
pool targeting Oasis: 
AAAAGAAGGUGGAGACAUU, 
GGGACCACCUGCAGCAUGA, 
GAAGGAGUAUGUGGAGUGU, and 
CAGGAGAGCCGUCGUAAGA; Thermo 
Scientific Dermacon, M-008579-01-0005) or 
control siRNA (Silencer Cy3 labeled negative 
control No.1 siRNA; Life Technologies, 
AM4621). Transfection was performed 12 hrs 
before treatment with sodium butyrate using 
Lipofectamine 2000 reagent (Life 
Technologies) according to the manufacturer’s 
protocols. 24 hrs after treatment with sodium 
butyrate, PAS staining was performed as 
described previously (36). The PAS-stained 
slide was counterstained with hematoxylin 
solution. 
 
RNA isolation and RT-PCR − Total RNA was 
isolated from the large intestine of 3-week old 
mice or LS174T cells using ISOGEN (Wako) 
according to the manufacturer's protocol. 
First-strand cDNA was synthesized in a 20 μl 
reaction volume using a random primer 
(Takara) and Moloney murine leukemia virus 
reverse transcriptase (Invitrogen). PCR was 
performed using each specific primer set in a 
total volume of 30 μl containing 0.8 μM of 
each primer, 0.2 mM dNTPs, 3 units of Taq 
polymerase, and 10× PCR buffer (Agilent). 
Primer sequences are summarized in 
Supplementary Information, Table S1. The 
PCR products were resolved by electrophoresis 
on a 4.8% acrylamide gel. The density of each 
band was quantified using the Adobe 
Photoshop Elements 2.0 Program (Adobe 
Systems Incorporated). 
 
Western blotting − For western blotting, 
proteins were extracted from LS174T cells 
using cell extraction buffer containing 10% 
SDS, 0.5 M EDTA (pH 8.0), 100 mM 
methionine, and a protease inhibitor mixture 
(MBL International). The lysates were 
incubated on ice for 45 min. After 
centrifugation at 16,000 × g for 15 min, the 
protein concentrations of the supernatants were 
determined. Protein-equivalent samples were 
loaded onto sodium dodecyl 
sulfate-polyacrylamide gels. Anti-β-actin 
(Sigma; 1:3000) and anti-OASIS (purified 
from a hybridoma as described previously (22, 
23)) antibodies were used for western blotting. 
The density of each band was quantified using 
the Adobe Photoshop Elements 2.0 Program 
(Adobe Systems Incorporated). 
 
Histological analysis and in situ hybridization 
− Large intestine from 3-week old mice was 
fixed overnight in 10% Formalin Neutral 
Buffer Solution (Wako). Samples were then 
dehydrated with ethanol, embedded in paraffin 
and sectioned (5 μm). Hematoxylin-eosin 
staining and PAS staining were performed 
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according to standard protocols. In situ 
hybridization was performed using 
digoxigenin-labeled cRNA probes 
(Supplementary information, Table S2). 
Antisense and sense probes were made by in 
vitro transcription in the presence of 
digoxigenin-labeled dUTP, using various 
cDNAs subcloned into the pGEM-Teasy vector 
(Promega) as templates. Large intestine 
isolated for in situ hybridization was frozen 
immediately and sectioned (6 μm). The frozen 
sections were fixed for 20 min with 4% 
formalin in phosphate-buffered saline (PBS, 
pH 7.4). The sections were then washed with 
PBS and treated with 0.1% proteinase K for 5 
min. After washing with PBS, the sections 
were re-fixed for 20 min with 4% formalin in 
PBS, and treated with 0.1M triethanolamine, 
2.5% anhydrous acetic acid for 10 min, 
followed by washing with PBS. Sections were 
prehybridized for 1 hr at 37°C in hybridization 
buffer (0.01% Dextran Sulfate, 0.01M 
Tris-HCl pH 8.0, 0.05 M NaCl, 50% 
Formamide, 0.2% Sarcosyl, 1× Denhardt’s 
solution, 0.5 mg/ml Yeast tRNA, 0.2 mg/ml 
Salmon testis DNA), and then hybridized 
overnight at 55°C in hybridization solution 
with 100 ng/ml cRNA probe. After washing 
with 4× saline sodium citrate buffer for 20 min 
at 60°C, the sections were further washed 2× 
saline sodium citrate buffer, 50% formamide 
for 30 min at 60°C. Sections were treated 
RNaseA in RNase buffer (10 mM Tris-HCl 
pH7.4, 1 mM 0.5 M EDTA (pH 8.0), 0.5 M 
NaCl) for 30 min at 37°C to remove 
un-hybridized probe. After RNase treatment, 
sections were washed with 2× saline sodium 
citrate buffer, 50% formamide for 30 min at 
60°C, and then blocked with 1.5% blocking 
reagent in 100 mM Tris-HCl pH 7.5, 150 mM 
NaCl for 1 hr at room temperature. For 
detection of digoxigenin-labeled cRNA probes, 
anti-digoxigenin antibody conjugated to 
alkaline phosphatase was used at a dilution of 
1:500, and color was developed by incubation 
with 4-nitro blue tetrazolium chloride and 
5-bromo-4-chloro-3-indolyl phosphate 
solution. 
 
Electron microscopy − Large intestine from 
3-week old mice was fixed in 1% 
glutaraldehyde in PBS for 15 min. After 
washing with distilled water, the tissues were 
post-fixed in 0.5% osmium tetroxide in 0.1 M 
cacodylate buffer for 30 min. Following 
dehydration, the tissues were embedded in 
EPON812, and ultra-thin sections were stained 
with uranyl acetate and lead citrate. Stained 
sections were visualized using a Hitachi 7100 
electron microscope operated at 80 kV. The 
mean cell area was determined using ImageJ 
software (NIH). 
 
Statistical analysis − Statistical comparisons 
were made using the unpaired-Student’s-t-test. 
Statistical significance between two samples 
was determined by a P value of less than 0.05. 
P values of less than 0.05, 0.01, or 0.001 are 
described as *P < 0.05, **P < 0.01, or 
***P<0.001, respectively. 
 
RESULTS 
OASIS was highly expressed in immature 
goblet cells of the large intestine − We 
previously reported that OASIS is expressed in 
osteoblasts and astrocytes (17, 20, 21, 23). To 
examine the tissue distribution of Oasis mRNA 
more precisely, we performed RT-PCR using 
mRNA isolated from various tissues of 3-week 
old mice. We detected strong Oasis mRNA 
signals in submandibular gland, lung, stomach, 
and in the large intestine where it was most 
intense (Fig.1A). Oasis mRNA was expressed 
highly in all portions of the large intestine 
except for the appendix. In contrast, the levels 
of Oasis mRNA were very low in the small 
intestine (Fig.1B). In the digestive tract, there 
are three distinct cell types, i.e. absorptive 
enterocytes, enteroendocrine cells, and goblet 
cells. To identify which of these cells 
expressed Oasis mRNA, we carried out in situ 
hybridization using Oasis cRNA probes. The 
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Oasis signals were focally detected in the base 
of the crypt, but not in the apical portion of the 
crypt (Fig.1C). In contrast, Gapdh mRNA was 
observed in all cells (both basal and apical) of 
the crypt. The cells expressing Oasis mRNA 
possessed vacuoles in their cytosol, indicating 
that OASIS is expressed in goblet cells. 
Moreover, the goblet cells at the base of the 
crypt are immature cells that are developing 
from intestinal stem cells (27, 37, 38). Thus, 
we concluded that the cells expressing OASIS 
were immature goblet cells. 
The numbers of mature goblet cells 
decreased in Oasis-/- mice − To elucidate the 
functions of OASIS in immature goblet cells, 
we first performed histological analysis in the 
Oasis-/- mice that we generated previously 
(22-24). The mice were born at the expected 
Mendelian ratios and were fertile, but showed 
impaired bone formation. However, the general 
morphology of all other tissues and organs was 
normal, and the architecture of the intestinal 
tract was unaffected. Additionally, formation 
of the crypt and differentiation of enterocytes 
also appeared normal. However, the apparent 
numbers of goblet cells that contained 
abundant vacuoles were decreased in Oasis-/- 
mice (Fig.2A). PAS staining showed a marked 
decrease in the number of cells containing 
mucus both in the proximal and distal large 
intestine of Oasis-/- mice (Fig.2B-E). In 
contrast, immature cells that contain less 
mucus were increased in the crypt epithelium, 
suggesting that the differentiation or 
maturation of goblet cells was inhibited in 
Oasis-/- mice. 
Next, we carried out electron microscopic 
examination of goblet cells in WT and Oasis-/- 
mice. Normal goblet cells have abundant 
cytoplasm containing large secretory vesicles 
(Fig.3A). In Oasis-/- mice, almost all goblet 
cells at the crypt base and in the lower portion 
of the crypt showed an abnormal ultrastructure 
in which both the number and size of vesicles 
were decreased, and the membranes of some 
vesicles were often fused (Fig.3B). Moreover, 
the rough endoplasmic reticulum was 
abnormally expanded in these cells (Fig.3D). 
In the upper portion of the crypt, cells with 
abnormal ultrastructure were also observed 
(Fig.3F). The other types of cells in the crypt 
epithelium, such as enteroendocrine cells and 
enterocytes, were morphologically intact in 
Oasis-/- mice (data not shown). Goblet cells 
are known to be differentiated from intestinal 
stem cells in the crypt base, and the mature 
goblet cells move to the apical portion of the 
crypt. We observed abnormal morphology of 
goblet cells from the base to the apical portion 
of the crypt in Oasis-/- mice, suggesting that 
deletion of the Oasis gene affected the 
differentiation or maturation of goblet cells 
from the intestinal cell lineage involving 
impairment of vesicle formation. 
OASIS functions in the terminal 
differentiation of goblet cells − We next 
focused on the roles of OASIS in goblet cell 
differentiation. Intestinal epithelial stem cells 
are determined to become cells of the secretory 
lineage such as goblet cells and 
enteroendocrine cells by Notch ligand 
Delta-like 1 (Dll1)(39), whereas absorptive 
enterocytes are specified by Notch and the 
transcription factor Hairy and enhancer of split 
1 (HES1) (40). Subsequently, secretory 
progenitor cells are specified to become goblet 
cells by the transcription factors, Atonal 
homolog 1 (ATOH1) (33, 34) and Growth 
factor independent 1 (GFI1) (41, 42). We 
examined the expression levels of various 
differentiation markers of the goblet cell 
lineages in the large intestine of Oasis-/- mice 
by RT-PCR. All genes involved in the primary 
differentiation from stem cells to early goblet 
cells or absorptive enterocytes were normally 
expressed in Oasis -/- mice (Fig.4A). Therefore, 
intestinal epithelial stem cells are correctly 
specified to both the goblet cell and absorptive 
enterocyte lineages. Interestingly, the 
expression of Trefoil factor 3 (Tff3), an early 
goblet cell marker, was significantly increased 
in Oasis-/- mice (Fig.4A). Conversely, the 
mature goblet cell markers, Muchin 2 (Muc2), 
Anterior gradient 2 (Agr2), and Resistin like 
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beta (Retnlb), were markedly decreased 
(Fig.4B). In situ hybridization revealed Tff3 
mRNA signals were observed diffusely in the 
crypt: the intensity was very faint in WT mice, 
but elevated in Oasis-/- mice (Fig.4D). Muc2 
mRNA signals were robustly observed 
throughout the crypt epithelium in WT mice, 
but were almost abolished in Oasis-/- mice 
(Fig.4E). These results suggest that 
differentiation from early to mature goblet cells 
is impaired in the large intestine of Oasis-/- 
mice. 
Recently, the Ets-domain transcription factor, 
SPDEF, was reported to be required for the 
terminal differentiation of goblet cells (35). In 
the large intestine, Spdef-/- mice showed a 
similar phenotype to that of Oasis-/- mice, i.e. 
goblet cells are correctly specified but the 
terminal differentiation of early to mature 
goblet cells was impaired. CREB4 is an ER 
resident CREB/ATF family transcription factor 
that is structurally very similar to OASIS. 
Interestingly, the expression of CREB4 was 
reported to be down-regulated in the intestine 
of Spdef-/- mice, indicating that CREB4 could 
be a direct target of SPDEF. We therefore 
examined whether the SPDEF-CREB4 
pathway is related to the OASIS signaling 
pathway. The expression of Spdef mRNA was 
not altered in the large intestine of Oasis -/- 
mice (Fig.4C and 4F), implying that OASIS 
does not regulate the expression of the Spdef 
gene. In contrast, the expression of CREB4 
was significantly decreased in Oasis -/- mice 
(Fig.4C). These data suggest that the 
expression of CREB4 is regulated by OASIS. 
Combined with the published data, CREB4 is 
therefore a common downstream target of 
OASIS and SPDEF, but the expression of 
CREB4 is regulated independently. 
Furthermore, CREB4 may be a marker for the 
terminal differentiation of goblet cells, and 
may function together with the OASIS 
signaling pathway in the maturation of goblet 
cells. 
Activation of OASIS during terminal 
differentiation of goblet cells − To investigate 
the roles of OASIS in the terminal 
differentiation of goblet cells, we examined the 
expression and activation of OASIS in the 
human colon cancer LS174T cell line. LS174T 
cells are secretory progenitors that can be 
induced to differentiate into goblet cells by 
treatment with sodium butyrate (36). In 
LS174T cells treated with 2 mM sodium 
butyrate for 24 hrs, PAS-positive secretory 
granules were produced (Fig. 5A), and the 
expression of mature goblet cell markers such 
as Muc2 and Agr2 was gradually induced from 
6 hrs after treatment (Fig.5B). Western blotting 
showed that the expression of full-length 
OASIS increased after 6 hrs treatment with 
sodium butyrate, peaking at 12 hrs following 
which it gradually decreased. The cleaved 
fragment of OASIS, p50 OASIS (OASIS 
N-terminus), also increased in synchrony with 
the expression of full-length OASIS, indicating 
that OASIS is activated during the 
differentiation of LS174T cells to mature 
goblet cells (Fig.5C). Because OASIS is 
activated in response to ER stress (17), it is 
possible that ER stress occurred during goblet 
cell differentiation. We examined the 
expression of ER stress markers after treatment 
with sodium butyrate. Messenger RNAs for the 
ER stress markers, Bip and Chop, were slightly 
but significantly up-regulated in accordance 
with the pattern of OASIS activation (Fig.5D). 
These findings suggest that mild ER stress is 
induced during goblet cell differentiation, and 
that OASIS is subjected to regulated 
intramembrane proteolysis in response to the 
mild ER stress. When differentiating into 
mature goblet cells, early goblet cells gradually 
start to produce abundant proteins such as 
MUC2, and these proteins are overloaded into 
the ER. Thus, mild ER stress during maturation 
of goblet cells could be derived from a high 
demand for synthesis and secretion of mucus 
materials. 
Our findings in Oasis -/- mice described 
above suggest that CREB4 could be expressed 
as a common downstream target of OASIS and 
SPDEF during differentiation of early to 
mature goblet cells. We therefore examined the 
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expression of Creb4 and Spdef mRNAs after 
treatment of LS174T cells with sodium 
butyrate. The expression of Creb4 mRNA was 
induced 6 hrs after treatment, the same time 
point at which expression of p50 OASIS 
(OASIS N-terminus) began (Fig.5E). Creb4 
mRNA expression then gradually decreased 
from 12 hrs after treatment. In contrast, 
although Spdef was also induced from 6 hrs, 
the expression level was maintained until 24 
hrs after treatment (Fig.5E), indicating that 
SPDEF is not downstream of OASIS.  
OASIS is required for the differentiation of 
goblet cells − To determine whether OASIS is 
indispensable for the differentiation of goblet 
cells, we examined the effects of Oasis 
knockdown using Oasis siRNA on the 
differentiation of LS174T cells. We confirmed 
that Oasis siRNA successfully and 
significantly suppressed the expression of 
OASIS in LS174T cells (Fig.6A). PAS-staining 
showed that secretory granules were 
significantly decreased in LS174T cells 
transfected with Oasis siRNA following 
treatment with sodium butyrate (Fig.6B). 
Furthermore, the mature goblet cell markers, 
Muc2 and Agr2, were dramatically 
down-regulated (Fig.6C). These data suggest 
that inhibition of OASIS expression impaired 
the terminal maturation of LS174T cells to 
goblet cells. 
Next, to analyze the relationship between 
the OASIS and SPDEF pathways, we checked 
the expression of SPDEF and CREB4 in 
LS174T cells treated with sodium butyrate. 
Even when the expression of OASIS was 
suppressed by siRNA, the up-regulation of 
Spdef mRNA following treatment with sodium 
butyrate was not affected. However, induction 
of CREB4 by sodium butyrate was 
significantly inhibited by transfection of 
LS174T cells with Oasis siRNA (Fig.6D). 
These findings support our hypothesis that 
CREB4, but not SPDEF, is downstream of 
OASIS. 
The expression of ER stress markers was 
slightly up-regulated during differentiation of 
LS174T cells to mature goblet cells (Fig.6E). 
However, the slight elevation of these genes 
was not affected by knockdown of Oasis 
mRNA, indicating that mild ER stress occurs 
prior to OASIS activation during the 
maturation of goblet cells. Taken together, our 
data suggest that OASIS plays an essential role 
in goblet cell differentiation following its 
activation by mild ER stress (Fig.7). 
DISCUSSION 
We previously demonstrated that OASIS 
promotes the differentiation of osteoblasts and 
is involved in bone formation (23-25). In this 
study, we found that Oasis is highly expressed 
in goblet cells at the crypt base in the large 
intestine. Goblet cells synthesize and secrete 
large amounts of mucus proteins, including 
mucin, and are similar to osteoblasts in that 
abundant proteins are loaded into the ER. 
Therefore, ER stress is easily induced in 
secretory goblet cells (43, 44). However, 
immature goblet cells do not produce mucus 
and do not undergo ER stress. During 
differentiation from secretory progenitor cells 
to mature goblet cells, immature cells develop 
the machinery for dealing with abundant 
proteins in the ER, including the UPR system. 
We did in fact demonstrate that ER stress is 
induced during goblet cell differentiation, and 
is followed by the induction of genes expressed 
in mature goblet cells. Thus, it is possible that 
ER stress is a trigger for the maturation of 
goblet cells. Similar phenomena are also seen 
in plasma cell differentiation. For the full 
development of antibody secretion, activation 
of the UPR is essential (45, 46). Taken together, 
previous data and our findings suggest that 
activation of the UPR by ER stress is required 
for the maturation of immature cells to 
“professional” secretory cells. 
In the large intestine of Oasis-/- mice, the 
number of mature goblet cells that contain 
abundant secretory granules was dramatically 
reduced. We found that Tff3, an early goblet 
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cell marker, was up-regulated, while mature 
goblet cell markers such as Muc2, Agr2, and 
Retnlb, were conversely down-regulated. 
Genes involved in the primary differentiation 
of immature goblet cells were not affected, 
indicating that intestinal stem cells are 
correctly specified to both secretory 
progenitors and absorptive enterocyte lineages. 
Thus, we concluded that the abnormal 
architectures observed in the crypt epithelium 
of Oasis-/- mice are caused by impaired 
terminal maturation of goblet cells. The 
anomalies in the large intestine of Oasis-/- 
mice are also reminiscent of the phenotype 
seen in Spdef-/- mice, which showed a 
profound loss of mature goblet cells (35). In 
this study, the authors used microarray 
analyses to show that OASIS is not 
down-regulated to any extent in Spdef -/- colon. 
Furthermore, we observed that the expression 
of SPDEF was not altered in the large intestine 
of Oasis-/- mice. These findings suggest that 
both genes are involved in the terminal 
differentiation of goblet cells, but by 
independent pathways. Interestingly, the 
expression of CREB4 was significantly 
down-regulated both in Oasis-/- and Spdef-/- 
large intestine, indicating that CREB4 is a 
common downstream target of OASIS and 
SPDEF that may be crucial for the terminal 
differentiation of goblet cells (Fig.7). CREB4 
is an ER-resident transmembrane transcription 
factor that is structurally similar to OASIS and 
contains a bZIP domain in its cytoplasmic 
region. Because OASIS also possesses a bZIP 
domain, CREB4 may form a heterodimer with 
OASIS that promotes the expression of target 
genes required for the differentiation of goblet 
cells. Previous characterization of Creb4 
knockout mice revealed anomalies in 
spermatogenesis (47), but a detailed analysis of 
the gut has not conducted. Because CREB4 
could be a key molecule for the maturation of 
goblet cells, further examination of Creb4-/- 
mice may enable further understanding of the 
molecular mechanisms involved in goblet cell 
differentiation. 
Goblet cells in the large intestine produce 
and secrete abundant mucus, which provides a 
protective barrier against bacteria and other 
harmful stimuli. Defects in this barrier 
contribute to chronic diseases, including colitis 
and cancer. Muc2-/- mice have been observed 
to develop spontaneous colitis (48). Similarly, 
intestinal trefoil factor-deficient mice exhibit 
increased susceptibility to dextran sodium 
sulfate-induced colitis (49). Therefore, 
impairment of goblet cell maturation may be 
linked to inflammation of the intestinal mucosa. 
Because mature goblet cells in Oasis-/- mice 
are drastically decreased, it is possible that the 
mice are also sensitive to colitis. Targeted 
deletion of the ER stress response transcription 
factor, XBP1, and the ER stress sensor, IRE1β, 
causes sensitivity to experimental colitis 
(50-52). However, the mechanisms of which 
are sensitive to colitis are not consistent with 
the case of mice deleted goblet cell 
differentiation-related genes such as Muc2 or 
Intestinal trefoil factor. Loss of Xbp1 or Ire1β 
induces severe ER stress in goblet cells, and 
leads to apoptosis and chronic inflammation in 
the large intestine. We observed abnormally 
expanded rough ER in the goblet cells of 
Oasis-/- mice, suggesting that the function of 
the ER in Oasis-/- goblet cells may be impaired 
due to sensitivity to ER stress. Thus, OASIS 
may play roles not only in the differentiation of 
goblet cells, but also in protecting these cells 
from ER stress. Indeed, overexpression of 
OASIS was reported to protect against ER 
stress-induced cell death (17). Although further 
examination into the relationship between 
OASIS function and the onset of colitis is 
required, it is possible that OASIS is a novel 
drug target for inflammatory bowel diseases 
such as ulcerous colitis. 
 
 
 
 
8
REFERENCES 
  
1. Rutkowski, D. T., and Kaufman, R. J. (2004) Trends Cell Biol 14, 20-28 
2. Zhang, K., and Kaufman, R. J. (2008) Nature 454, 455-462 
3. Schröder, M., and Kaufman, R. J. (2005) Mutat Res 569, 29-63 
4. Ron, D. (2002) J Clin Invest 110, 1383-1388 
5. Kaufman, R. J. (2002) J Clin Invest 110, 1389-1398 
6. Harding, H. P., Novoa, I., Zhang, Y., Zeng, H., Wek, R., Schapira, M., and Ron, D. (2000) Mol Cell 
6, 1099-1108 
7. Li, M., Baumeister, P., Roy, B., Phan, T., Foti, D., Luo, S., and Lee, A. S. (2000) Mol Cell Biol 20, 
5096-5106 
8. Yoshida, H., Haze, K., Yanagi, H., Yura, T., and Mori, K. (1998) J Biol Chem 273, 33741-33749 
9. Ng, D. T., Spear, E. D., and Walter, P. (2000) J Cell Biol 150, 77-88 
10. Travers, K. J., Patil, C. K., Wodicka, L., Lockhart, D. J., Weissman, J. S., and Walter, P. (2000) Cell 
101, 249-258 
11. Nakagawa, T., Zhu, H., Morishima, N., Li, E., Xu, J., Yankner, B. A., and Yuan, J. 
(2000) Nature 403, 98-103 
12. Urano, F., Wang, X., Bertolotti, A., Zhang, Y., Chung, P., Harding, H. P., and Ron, D. 
(2000) Science 287, 664-666 
13. Rutkowski, D. T., and Hegde, R. S. (2010) J Cell Biol 189, 783-794 
14. Hotamisligil, G. S. (2010) Cell 140, 900-917 
15. Kondo, S., Saito, A., Asada, R., Kanemoto, S., and Imaizumi, K. (2011) IUBMB Life 63, 233-239 
16. Asada, R., Kanemoto, S., Kondo, S., Saito, A., and Imaizumi, K. (2011) J Biochem 149, 507-518 
17. Kondo, S., Murakami, T., Tatsumi, K., Ogata, M., Kanemoto, S., Otori, K., Iseki, K., Wanaka, A., 
and Imaizumi, K. (2005) Nat Cell Biol 7, 186-194 
18. Murakami, T., Kondo, S., Ogata, M., Kanemoto, S., Saito, A., Wanaka, A., and Imaizumi, K. (2006) 
J Neurochem 96, 1090-1100 
19. Saito, A., Hino, S., Murakami, T., Kondo, S., and Imaizumi, K. (2007) Antioxid Redox Signal 9, 
563-571 
20. Honma, Y., Kanazawa, K., Mori, T., Tanno, Y., Tojo, M., Kiyosawa, H., Takeda, J., Nikaido, T., 
Tsukamoto, T., Yokoya, S., and Wanaka, A. (1999) Brain Res Mol Brain Res 69, 93-103 
21. Nikaido, T., Yokoya, S., Mori, T., Hagino, S., Iseki, K., Zhang, Y., Takeuchi, M., Takaki, H., 
Kikuchi, S., and Wanaka, A. (2001) Histochem Cell Biol 116, 141-148 
22. Chihara, K., Saito, A., Murakami, T., Hino, S., Aoki, Y., Sekiya, H., Aikawa, Y., Wanaka, A., and 
Imaizumi, K. (2009)J Neurochem 110, 956-965 
23. Murakami, T., Saito, A., Hino, S., Kondo, S., Kanemoto, S., Chihara, K., Sekiya, H., Tsumagari, K., 
Ochiai, K., Yoshinaga, K., Saitoh, M., Nishimura, R., Yoneda, T., Kou, I., Furuichi, T., Ikegawa, S., 
Ikawa, M., Okabe, M., Wanaka, A., and Imaizumi, K. (2009) Nat Cell Biol 11, 1205-1211 
24. Murakami, T., Hino, S., Nishimura, R., Yoneda, T., Wanaka, A., and Imaizumi, K. (2011) Bone 48, 
514-523 
25. Funamoto, T., Sekimoto, T., Murakami, T., Kurogi, S., Imaizumi, K., and Chosa, E. (2011) Bone 49, 
724-732 
26. Cheng, H., and Leblond, C. P. (1974) Am J Anat 141, 537-561 
27. Gordon, J. I. (1989) J Cell Biol 108, 1187-1194 
28. Pinto, D., Gregorieff, A., Begthel, H., and Clevers, H. (2003) Genes Dev 17, 1709-1713 
29. Nakamura, T., Tsuchiya, K., and Watanabe, M. (2007) J Gastroenterol 42, 705-710 
30. Oettgen, P., Finger, E., Sun, Z., Akbarali, Y., Thamrongsak, U., Boltax, J., Grall, F., Dube, A., Weiss, 
A., Brown, L., Quinn, G., Kas, K., Endress, G., Kunsch, C., and Libermann, T. A. (2000) J Biol 
Chem 275, 1216-1225 
 
9
31. Ghadersohi, A., and Sood, A. K. (2001) Clin Cancer Res 7, 2731-2738 
32. Noah, T. K., Kazanjian, A., Whitsett, J., and Shroyer, N. F. (2010) Exp Cell Res 316, 452-465 
33. Yang, Q., Bermingham, N. A., Finegold, M. J., and Zoghbi, H. Y. (2001) Science 294, 2155-2158 
34. Shroyer, N. F., Helmrath, M. A., Wang, V. Y., Antalffy, B., Henning, S. J., and Zoghbi, H. Y. 
(2007)Gastroenterology 132, 2478-2488 
35. Gregorieff, A., Stange, D. E., Kujala, P., Begthel, H., van den Born, M., Korving, J., Peters, P. J., 
and Clevers, H. (2009) Gastroenterology 137, 1333-1345.e1331-1333 
36. Hatayama, H., Iwashita, J., Kuwajima, A., and Abe, T. (2007) Biochem Biophys Res Commun 356, 
599-603 
37. Mills, J. C., and Gordon, J. I. (2001) Proc Natl Acad Sci U S A 98, 12334-12336 
38. Shaker, A., and Rubin, D. C. (2010) Transl Res 156, 180-187 
39. Crosnier, C., Vargesson, N., Gschmeissner, S., Ariza-McNaughton, L., Morrison, A., and Lewis, J. 
(2005) Development 132, 1093-1104 
40. Jensen, J., Pedersen, E. E., Galante, P., Hald, J., Heller, R. S., Ishibashi, M., Kageyama, R., 
Guillemot, F., Serup, P., and Madsen, O. D. (2000) Nat Genet 24, 36-44 
41. Shroyer, N. F., Wallis, D., Venken, K. J., Bellen, H. J., and Zoghbi, H. Y. (2005) Genes Dev 19, 
2412-2417 
42. Bjerknes, M., and Cheng, H. (2010) Dev Biol 345, 49-63 
43. Oyadomari, S., Koizumi, A., Takeda, K., Gotoh, T., Akira, S., Araki, E., and Mori, M. (2002) J Clin 
Invest 109, 525-532 
44. Fonseca, S. G., Gromada, J., and Urano, F. (2011) Trends Endocrinol Metab 22, 266-274 
45. Reimold, A. M., Iwakoshi, N. N., Manis, J., Vallabhajosyula, P., Szomolanyi-Tsuda, E., Gravallese, 
E. M., Friend, D., Grusby, M. J., Alt, F., and Glimcher, L. H. (2001) Nature 412, 300-307 
46. Iwakoshi, N. N., Lee, A. H., Vallabhajosyula, P., Otipoby, K. L., Rajewsky, K., and Glimcher, L. H. 
(2003) Nat Immunol 4, 321-329 
47. Adham, I. M., Eck, T. J., Mierau, K., Müller, N., Sallam, M. A., Paprotta, I., Schubert, S., 
Hoyer-Fender, S., and Engel, W. (2005) Mol Cell Biol 25, 7657-7664 
48. Heazlewood, C. K., Cook, M. C., Eri, R., Price, G. R., Tauro, S. B., Taupin, D., Thornton, D. J., Png, 
C. W., Crockford, T. L., Cornall, R. J., Adams, R., Kato, M., Nelms, K. A., Hong, N. A., Florin, T. 
H., Goodnow, C. C., and McGuckin, M. A. (2008) PLoS Med 5, e54 
49. Mashimo, H., Wu, D. C., Podolsky, D. K., and Fishman, M. C. (1996) Science 274, 262-265 
50. Bertolotti, A., Wang, X., Novoa, I., Jungreis, R., Schlessinger, K., Cho, J. H., West, A. B., and Ron, 
D. (2001) J Clin Invest 107, 585-593 
51. Kaser, A., Lee, A. H., Franke, A., Glickman, J. N., Zeissig, S., Tilg, H., Nieuwenhuis, E. E., Higgins, 
D. E., Schreiber, S., Glimcher, L. H., and Blumberg, R. S. (2008) Cell 134, 743-756 
52. Kaser, A., and Blumberg, R. S. (2011) Gastroenterology 140, 1738-1747 
 
 
 
FOOTNOTES 
 
We thank S. Nakagawa for technical support. This work was partly supported by grants from the Japan 
Society for the Promotion of Science KAKENHI (#22020030, #22800049), Sumitomo Foundation, 
Mochida Memorial Foundation for Medical and Pharmaceutical Research, Astellas Foundation for 
Research on Metabolic Disorders, Takeda Science Foundation, The Pharmacological Research 
Foundation Tokyo, Daiichi-Sankyo Foundation of Life Science, and The Naito Foundation. 
 
The abbreviations used are: bZIP, basic leucine zipper; ER, endoplasmic reticulum; UPR, unfolded 
 
10
protein response; OASIS, old astrocyte specifically induced substance; BBF-2, box B-binding factor-2; 
BBF2H7, BBF2 human homolog on chromosome 7; CREB, cyclic AMP-response element-binding 
protein; CREB4, cyclic AMP-response element-binding protein 4; BiP, immunoglobulin heavy 
chain-binding protein; ERAD, ER-associated degradation; Col1, type I collagen; SPDEF, SAM-pointed 
domain-containing ETS-like factor; Atoh1, atonal homolog 1; Hes1, hairy and enhancer of split 1; Dll1, 
delta-like 1; Gfi1, growth factor independent 1; Muc2, muchin 2; Agr2, anterior gradient 2; Retnlb, 
restin like beta; Tff3, trefoil factor 3; XBP1, X-box binding protein 1; IRE1, inositol requiring 1; 
GAPDH, glyceraldehyde-3-phosphate dehydrogenase 
 
 
FIGURE LEGENDS 
 
Fig. 1. The expression of Oasis mRNA in the large intestine. A, RT-PCR analysis of Oasis mRNA in 
various tissues from 3-week old mice. Oasis mRNA is highly expressed in the large intestine. B, The 
expression of Oasis mRNA in each region of the large intestine. Right; quantitative analysis of Oasis 
mRNA. C, Hematoxylin-Eosin staining (HE) in the large intestine. Many goblet cells with 
mucus-containing vacuoles are observed in the crypt. D and E, in situ hybridization analysis of Oasis 
mRNA (D) and Gapdh mRNA (E) in the large intestine. Oasis mRNA is expressed in the lower portion 
of the crypt. 
 
Fig. 2. Anomalies of goblet cells in the large intestine of Oasis-/- mice. A, HE staining; B, PAS 
staining. The numbers of goblet cells with vacuoles are severely decreased in Oasis-/- mice. C and D, 
PAS-Hematoxylin counter staining of WT and Oasis-/- large intestine. C, proximal large intestine; D, 
distal large intestine. E, The percentages of PAS-positive goblet cells in the crypt of the large intestine in 
WT and Oasis-/- mice. Data are mean ± s.d., n=5, ***P < 0.001, unpaired Student’s t-test. 
 
Fig. 3. Electron microscopy of goblet cells in the large intestine. A and B, images of goblet cells at 
the crypt base in the large intestine. C and D, high magnification of the rough ER in panels A and B. 
Note that rough ER in Oasis-/- goblet cells displays aberrant expansion. E and F, goblet cells in the 
upper portion of the crypt. The numbers of mucus vesicles are decreased and the membrane of some 
vesicles are often fused in goblet cells of Oasis-/- large intestine. Scale bars, 4μm (A, B, E, and F), 
1.6 μm (C and D) 
 
Fig. 4. The expression of goblet cell markers in the large intestine. A, RT-PCR of genes involved in 
primary differentiation from intestinal stem cells and an early goblet cell marker, Tff3. Note that the 
expression of Tff3 is significantly elevated in Oasis-/- mice. B, RT-PCR of mature goblet cell markers. 
C, RT-PCR analysis of Spdef and Creb4. Data are mean ± s.d., n=3, *P < 0.05, **P < 0.01, unpaired 
Student’s t-test. D-F, in situ hybridization of Tff3 (D), Muc2 (E), and Spdef (F) in the large intestine.  
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Fig. 5. Gene expression and OASIS activation during goblet cell maturation. A, PAS staining of 
LS174T cells 24 hrs after treatment with sodium butyrate. LS174T cells are completely differentiated to 
mature goblet cells containing PAS-positive mucus 24 hrs following treatment. B, RT-PCR of mature 
goblet cell markers in LS174T cells treated with sodium butyrate. The expression levels of mature 
goblet cell markers are increased after treatment with sodium butyrate. C, Western blot analysis of 
OASIS in LS174T cells treated with sodium butyrate (left). Quantification of the amounts of OASIS 
N-terminus (right). D, RT-PCR of ER stress markers during LS174T cell differentiation. E, RT-PCR of 
Spdef and Creb4 mRNAs in LS174T cells treated with sodium butyrate. Data are mean ± s.d., n=5. 
 
Fig. 6. OASIS is required for the terminal differentiation of goblet cells. A, RT-PCR of Oasis 
mRNA in LS174T cells 12 hrs after transfection with Oasis siRNA. The expression of Oasis mRNA is 
significantly suppressed by the siRNA. B, PAS staining of LS174T cells 24 hrs after treatment with 
sodium butyrate. Oasis knockdown results in inhibition of goblet cell maturation. C-E, RT-PCR of 
mature goblet cell markers (C), Spdef and Creb4 (D), and ER stress markers (E) in LS174T cells treated 
with sodium butyrate following transfection with Oasis siRNA. Data are mean ± s.d., n=5. *P < 0.05, 
**P < 0.01, unpaired Student’s t-test. 
 
Fig.7. Putative roles of OASIS in the differentiation of goblet cells in the large intestine. 
 
 
SUPPLEMENTAL TABLE LEDEND 
 
Table 1. RT-PCR was performed using each specific primer set. 
Table2. Digoxigenin-labeled probes for each gene. 
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